TMED7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.116600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.022630E-01
Normal-vs-Stage2
5.460200E-01
Normal-vs-Stage3
5.557400E-01
Normal-vs-Stage4
2.291600E-01
Stage1-vs-Stage2
4.358800E-01
Stage1-vs-Stage3
1.008440E-02
Stage1-vs-Stage4
4.950600E-01
Stage2-vs-Stage3
2.165000E-01
Stage2-vs-Stage4
8.482200E-02
Stage3-vs-Stage4
9.058100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.157400E-01
Normal-vs-AfricanAmerican
4.859600E-01
Normal-vs-Asian
7.929200E-01
Caucasian-vs-AfricanAmerican
6.667400E-01
Caucasian-vs-Asian
4.905000E-01
AfricanAmerican-vs-Asian
4.721200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.974600E-01
Normal-vs-Female
5.180200E-01
Male-vs-Female
4.586000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.322400E-01
Normal-vs-Age(41-60Yrs)
2.781200E-01
Normal-vs-Age(61-80Yrs)
6.369400E-01
Normal-vs-Age(81-100Yrs)
8.639200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.192600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.837400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.535400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.386440E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.652000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.176800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.605400E-01
Normal-vs-Daily Drinker
9.596000E-01
Normal-vs-Weekly Drinker
7.788200E-01
Normal-vs-Occasional Drinker
2.415800E-01
Normal-vs-Social Drinker
5.405200E-01
Non Drinker-vs-Daily Drinker
6.372800E-01
Non Drinker-vs-Weekly Drinker
9.798600E-01
Non Drinker-vs-Occasional Drinker
2.209700E-02
Non Drinker-vs-Social Drinker
4.024200E-01
Daily Drinker-vs-Weekly Drinker
6.994400E-01
Daily Drinker-vs-Occasional Drinker
1.518010E-02
Daily Drinker-vs-Social Drinker
2.921000E-01
Weekly Drinker-vs-Occasional Drinker
3.452400E-02
Weekly Drinker-vs-Social Drinker
5.208200E-01
Occasional Drinker-vs-Social Drinker
1.227000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.105400E-01
Normal-vs-Grade 2
6.584100E-02
Normal-vs-Grade 3
6.852100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.338200E-01
Grade 1-vs-Grade 3
4.467400E-01
Grade 1-vs-Grade 4
2.105400E-01
Grade 2-vs-Grade 3
9.038200E-01
Grade 2-vs-Grade 4
6.584100E-02
Grade 3-vs-Grade 4
6.852100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.124600E-01
Normal-vs-NonDiabetic
5.450200E-01
Diabetic-vs-NonDiabetic
4.644600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.604800E-01
Normal-vs-NoPancreatitis
5.040200E-01
Pancreatitis-vs-NoPancreatitis
5.838700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.388200E-01
Normal-vs-N1
5.296000E-01
N0-vs-N1
7.994400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.377000E-01
Normal-vs-TP53-NonMutant
4.963600E-01
TP53-Mutant-vs-TP53-NonMutant
1.612970E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
